(1)
Wang, X. Stocks Valuation of Johnson & Johnson (J&J): Analysis of Ongoing Risks of Pharmaceuticals Corporations in Post-Pandemic Era. HBEM 2022, 1, 36-40. https://doi.org/10.54097/hbem.v1i.2315.